No abstract available
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Aged
-
Antigens, CD / analysis
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Bone Marrow / pathology
-
Bone Marrow Transplantation
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Dendritic Cells / chemistry
-
Dendritic Cells / pathology*
-
Disease Progression
-
Doxorubicin / administration & dosage
-
Humans
-
Immunophenotyping
-
Leukemia, Myelomonocytic, Acute / pathology
-
Lymph Nodes / pathology
-
Lymphoma, Non-Hodgkin / diagnosis
-
Lymphoma, Non-Hodgkin / drug therapy
-
Lymphoma, Non-Hodgkin / pathology*
-
Lymphoma, Non-Hodgkin / surgery
-
Male
-
Mercaptopurine / administration & dosage
-
Methotrexate / administration & dosage
-
Middle Aged
-
Prednisone / administration & dosage
-
Prognosis
-
Remission Induction
-
Skin Neoplasms / diagnosis
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology*
-
Skin Neoplasms / surgery
-
Transplantation, Homologous
-
Vincristine / administration & dosage
Substances
-
Antigens, CD
-
Cytarabine
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Mercaptopurine
-
Asparaginase
-
Prednisone
-
Methotrexate
-
Daunorubicin
Supplementary concepts
-
CCG-141 protocol
-
CHOP protocol